Close menu




February 3rd, 2022 | 11:56 CET

dynaCERT, AMD, Alibaba - Clean air for big growth

  • Innovations
  • Technology
  • Hydrogen
Photo credits: pixabay.com

Pictures of the truck protest convoys in Canada also illustrate on the sidelines the extent of air pollution caused by CO2 exhaust gases. The company dynaCERT, also from Canada, offers its patented retrofit solution for combustion engines to counter these emissions and has enormous growth potential. AMD continues to grow through its merger with Chinese Company Xilinx. Alibaba continues to expand its business with cloud solutions. We take a look at three exciting candidates.

time to read: 3 minutes | Author: Juliane Zielonka
ISIN: DYNACERT INC. | CA26780A1084 , ALIBABA GR.HLDG SP.ADR 8 | US01609W1027 , ADVANCED MIC.DEV. DL-_01 | US0079031078

Table of contents:


    Jim Payne, CEO, dynaCERT Inc.
    "[...] We are committed to stay as the number one Canadian and global leader in the Hydrogen-On-Demand diesel technology [...]" Jim Payne, CEO, dynaCERT Inc.

    Full interview

     

    dynaCERT - Fresh air for sustainability investors

    The Canadian city of Ottawa comes into focus due to the protest of thousands of truck drivers. The images of endlessly long truck convoys highlight the otherwise little-visible dimensions of international trade routes and the associated CO2 emissions in heavy goods traffic.

    An internal combustion engine runs in every one of these trucks, around 1 billion worldwide and every day. In addition, 100 million new internal combustion engines are built every year. Whether in ships, buses, agricultural and construction machinery, or even trucks; all internal combustion engines developed on diesel technology contribute to global air pollution through their CO2 emissions. Transportation is essential to the global economy, but the level of air pollution can be reduced through patented and innovative technology.

    Located just 450km from Ottawa is Toronto-based dynaCERT Inc. dynaCERT designs, manufactures and markets the installation of transportable hydrogen generator retrofit products for internal combustion engines. Both in Canada, the USA and internationally. dynaCERT offers a patented retrofit product for diesel engines in trucks and other frequently used transportation vehicles. The patented technology provides a power boost by injecting hydrogen and oxygen into the air intake from the internal combustion engine. It results in higher fuel efficiency and lower carbon emissions. Hydrocarbons and carbon dioxides are reduced. The hydrogen fuel contains virtually no CO2. The diesel fuel burns better with the help of hydrogen, according to the Company, because a higher flame speed is produced. More clean air, more power, and for the majority of popular diesel engines worldwide.

    Investors focused on sustainability and environmental awareness can take advantage of the opportunity to invest in a solid Canadian company for more clean air in a global cleantech market with growth potential.

    Q4 2021 Earnings Call: AMD on track for growth

    Not every truck is rolling these days. The automotive industry is also facing challenges. The reason: the global semiconductor crisis, caused by supply chain slumps. For example, Elon Musk supplies his Tesla customers with cars with a USB port connection in the driver's cockpit. However, the new owners currently discover only yawning emptiness in this place.

    But semiconductor producer AMD is just beginning to conquer the automotive segment for itself. CEO Lisa Su said about this in the earnings call on February 1, 2022: "It's a nice, stable business over many years. It's smaller, but it has grown well." What has grown is AMD in particular. That is because, according to Ms. Su, "2021 was a banner year for AMD, as we exceeded our aggressive growth targets and delivered another record year. Our business units grew significantly and set a new annual revenue record, with data center revenue more than doubling YOY. Annual revenue increased 68% to a record 16.4 billion, and we increased gross margin for the sixth consecutive year."

    Finally, AMD is getting the green light from China. With its USD 35 billion acquisition of Xilinx, the deal is now expected to close this quarter after more than a year's delay. With this merger, AMD is tapping into another lucrative market entry in divisions such as telecommunications, including 5G. The air for competitor Intel is getting thin because AMD is catching up. Investors should stay invested. And those who want to stock up on AMD shares should not wait too long.

    Alibaba - Room to move up with its own cloud

    Speaking of China, when investor legends like Charlie Munger, Warren Buffett and Monish Pabrai invest in Alibaba, they expect an exceptionally high return on investment. US value investors all have one trait in common: a preternatural amount of patience to see the power of compound interest unfold.

    In the last quarter, Alibaba posted a 6% EBITA improvement. The Silk Road digital route continues to expand with Jack Ma's foray into the cloud computing business. Alibaba is known for its versatility in e-commerce, retail, internet and accompanying technology.

    Due to its immense growth the internet giant is more often than not catching the eye of government regulators. China is known to do things its way. A risk all investors should be aware of. However, the future prospect of conquering more world markets in the digital cloud is a growth opportunity that investors should not miss. While Amazon, with its cloud computing service AWS, shows an operating margin of about 30%, the margin of the Alibaba cloud is still in the low single digits. A cup of green tea and composure help with this global player, not only the grand seigneurs of Value investors, to keep calm and watch the Company grow.


    dynaCERT is an investment with focus on sustainability, climate protection and innovation. AMD is competing with Intel and expanding business through the merger with Xilinx - hold or buy. Alibaba is on a value course with long-term growth prospects.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Juliane Zielonka

    Born in Bielefeld, she studied German, English and psychology. The emergence of the Internet in the early '90s led her from university to training in graphic design and marketing communications. After years of agency work in corporate branding, she switched to publishing and learned her editorial craft at Hubert Burda Media.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read